Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. [electronic resource]
Producer: 20050509Description: 2109-17 p. digitalISSN:- 1538-3598
- Abciximab
- Aged
- Angioplasty, Balloon, Coronary
- Antibodies, Monoclonal -- therapeutic use
- Drug Delivery Systems
- Female
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Immunosuppressive Agents -- administration & dosage
- Male
- Middle Aged
- Myocardial Infarction -- therapy
- Platelet Aggregation Inhibitors -- therapeutic use
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Single-Blind Method
- Sirolimus -- administration & dosage
- Stents
- Tirofiban
- Tyrosine -- analogs & derivatives
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.